908 Devices (MASS) Competitors $8.51 +0.11 (+1.31%) Closing price 04:00 PM EasternExtended Trading$8.51 0.00 (0.00%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MASS vs. ALNT, EYPT, AEHR, TRNS, CTKB, LAB, QSI, FEIM, QTRX, and PREShould you be buying 908 Devices stock or one of its competitors? The main competitors of 908 Devices include Allient (ALNT), Eyepoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), Quantum-Si (QSI), Frequency Electronics (FEIM), Quanterix (QTRX), and Prenetics Global (PRE). These companies are all part of the "measuring and control equipment" industry. 908 Devices vs. Its Competitors Allient Eyepoint Pharmaceuticals Aehr Test Systems Transcat Cytek Biosciences Standard BioTools Quantum-Si Frequency Electronics Quanterix Prenetics Global 908 Devices (NASDAQ:MASS) and Allient (NASDAQ:ALNT) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings. Is MASS or ALNT more profitable? Allient has a net margin of 2.75% compared to 908 Devices' net margin of -30.54%. Allient's return on equity of 9.97% beat 908 Devices' return on equity.Company Net Margins Return on Equity Return on Assets 908 Devices-30.54% -24.30% -18.55% Allient 2.75%9.97%4.67% Which has more risk & volatility, MASS or ALNT? 908 Devices has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, Allient has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Do insiders & institutionals hold more shares of MASS or ALNT? 88.1% of 908 Devices shares are owned by institutional investors. Comparatively, 61.6% of Allient shares are owned by institutional investors. 23.7% of 908 Devices shares are owned by insiders. Comparatively, 15.6% of Allient shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer MASS or ALNT? In the previous week, Allient had 7 more articles in the media than 908 Devices. MarketBeat recorded 14 mentions for Allient and 7 mentions for 908 Devices. Allient's average media sentiment score of 0.65 beat 908 Devices' score of -0.07 indicating that Allient is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 908 Devices 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Allient 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, MASS or ALNT? Allient has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio908 Devices$59.63M5.12-$72.21M-$0.54-15.76Allient$519.60M1.79$13.17M$0.8663.86 Do analysts prefer MASS or ALNT? 908 Devices presently has a consensus price target of $8.00, suggesting a potential downside of 5.99%. Allient has a consensus price target of $47.50, suggesting a potential downside of 13.51%. Given 908 Devices' stronger consensus rating and higher possible upside, equities research analysts clearly believe 908 Devices is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 908 Devices 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.80Allient 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryAllient beats 908 Devices on 10 of the 17 factors compared between the two stocks. Get 908 Devices News Delivered to You Automatically Sign up to receive the latest news and ratings for MASS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASS vs. The Competition Export to ExcelMetric908 DevicesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$305.17M$7.59B$6.14B$10.76BDividend YieldN/A1.13%5.71%4.83%P/E Ratio-15.7627.3629.8028.54Price / Sales5.1228.19499.08189.72Price / CashN/A22.5936.6160.67Price / Book2.595.2612.016.60Net Income-$72.21M$178.09M$3.32B$276.82M7 Day Performance-0.58%1.31%1.59%1.99%1 Month Performance12.57%2.15%6.15%2.56%1 Year Performance157.10%5.12%61.11%32.85% 908 Devices Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASS908 Devices1.3195 of 5 stars$8.51+1.3%$8.00-6.0%+146.3%$305.17M$59.63M-15.7660News CoverageAnalyst ForecastALNTAllient2.7035 of 5 stars$51.05+3.7%$47.50-7.0%+228.4%$834.64M$529.97M59.362,525News CoverageAnalyst ForecastGap UpEYPTEyepoint Pharmaceuticals2.2689 of 5 stars$12.03+3.4%$28.67+138.3%+15.5%$801.63M$43.27M-4.49120AEHRAehr Test Systems2.1061 of 5 stars$28.80+16.3%$24.00-16.7%+64.1%$742.96M$58.97M-130.9190Analyst ForecastGap UpTRNSTranscat4.0438 of 5 stars$71.01+2.5%$112.20+58.0%-37.8%$645.35M$278.42M49.661,245Analyst UpgradeCTKBCytek Biosciences1.3344 of 5 stars$4.04+2.3%$5.60+38.6%-14.2%$502.53M$200.45M-80.80500Analyst ForecastLABStandard BioTools2.024 of 5 stars$1.28+0.8%$1.55+21.1%-22.5%$485.13M$174.43M-4.00620News CoverageQSIQuantum-Si2.6108 of 5 stars$2.59+13.6%$3.48+34.2%+177.7%$461.69M$3.06M-3.81150Gap UpFEIMFrequency Electronics2.5505 of 5 stars$36.72+7.9%$43.00+17.1%+224.3%$331.67M$69.81M16.04200Positive NewsQTRXQuanterix2.3879 of 5 stars$5.90+0.7%$11.75+99.2%-52.3%$272.29M$137.42M-3.24460News CoverageGap UpPREPrenetics Global0.6819 of 5 stars$16.24+8.3%$9.00-44.6%+267.4%$194.77M$30.62M-4.071 Related Companies and Tools Related Companies Allient Alternatives Eyepoint Pharmaceuticals Alternatives Aehr Test Systems Alternatives Transcat Alternatives Cytek Biosciences Alternatives Standard BioTools Alternatives Quantum-Si Alternatives Frequency Electronics Alternatives Quanterix Alternatives Prenetics Global Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASS) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredFree: The Crypto Summit That Could Change Your LifeFed cuts unleash crypto's next wave The smart money is already moving. This is your chance to see their car...Crypto 101 Media | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 908 Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
